BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ho CM, Chen CL, Chang CH, Lee MR, Wang JY, Hu RH, Lee PH. Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment. Biomedicines 2021;9:891. [PMID: 34440095 DOI: 10.3390/biomedicines9080891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Méndez-sánchez N, Teschke R. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00002-1] [Reference Citation Analysis]
2 Wang M, Wu S, Zhang M, He J. Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1044808] [Reference Citation Analysis]
3 Woo SM, Alhaqqan DM, Gildea DT, Patel PA, Cundra LB, Lewis JH. Highlights of the drug-induced liver injury literature for 2021. Expert Rev Gastroenterol Hepatol 2022;16:767-85. [PMID: 35839342 DOI: 10.1080/17474124.2022.2101996] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Weber S, Gerbes AL. Challenges and Future of Drug-Induced Liver Injury Research-Laboratory Tests. Int J Mol Sci 2022;23:6049. [PMID: 35682731 DOI: 10.3390/ijms23116049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]